You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Small Cell Bladder Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Small Cell Neuroendocrine Carcinoma of Bladder, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore

Recruiting
  • Small Cell Neuroendocrine Carcinoma of Bladder
  • +2 more
  • Washington, District of Columbia
  • +1 more
Jun 27, 2022

Bladder Cancer Trial in Houston (Prophylactic Cranial Irradiation (PCI), Brain X-ray)

Active, not recruiting
  • Bladder Cancer
  • Prophylactic Cranial Irradiation (PCI)
  • Brain X-ray
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 18, 2022

Urothelial Carcinoma, Urothelial Cancer, Lung Tumors Trial run by the NCI (EP0057, olaparib)

Recruiting
  • Urothelial Carcinoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Advanced Malignant Solid Tumor, Anal Carcinoma, Biliary Tract Carcinoma Trial in Jacksonville (Clinical Encounter, Home Health

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +18 more
  • Clinical Encounter
  • +3 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jul 24, 2023

Quantifying Systemic Immunosuppression to Personalize Cancer

Recruiting
  • Melanoma
  • +6 more
  • MDSC quantification
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Nov 11, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +41 more
  • Ipilimumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 11, 2022

Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer Trial (VLS-1488)

Not yet recruiting
  • Advanced Solid Tumor
  • +15 more
  • (no location specified)
Jun 2, 2023

Investigate Rectal Mucus in Aero-Digestive Tract Cancer.

Recruiting
  • Non Small Cell Lung Cancer
  • +4 more
  • Oricol Test
  • Exeter, United Kingdom
    Royal Devon & Exeter NHS Foundation Trust
Jan 24, 2023

NSCLC, Non-Small Cell Lung Adenocarcinoma, Non-Small Cell Squamous Lung Cancer Trial in Grand Rapids, San Antonio, Fairfax

Recruiting
  • Non-small Cell Lung Cancer
  • +10 more
  • Grand Rapids, Michigan
  • +2 more
Apr 25, 2023

Advanced Clear Cell Renal Cell Carcinoma, Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant, Infiltrating Bladder

Active, not recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +35 more
  • Cabozantinib S-malate
  • +2 more
  • Duarte, California
  • +7 more
Jan 3, 2023

Esophagus Cancer, Bladder Cancer, Liver Cancer Trial (Intravenous injection of P-IL-2, P-IL-2 plus Anti-PD-1 Monoclonal

Not yet recruiting
  • Esophagus Cancer
  • +4 more
  • Intravenous injection of P-IL-2
  • P-IL-2 plus Anti-PD-1 Monoclonal Antibody
  • (no location specified)
Apr 24, 2023

Bladder Small Cell Neuroendocrine Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Bladder Urothelial Carcinoma

Recruiting
  • Bladder Small Cell Neuroendocrine Carcinoma
  • +16 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Mar 23, 2022

Advanced Cancer, Advanced Malignancies, Bladder Cancer Trial (AB598, Zimberelimab, Carboplatin)

Not yet recruiting
  • Advanced Cancer
  • +11 more
  • (no location specified)
May 26, 2023

Breast Cancer, Melanoma, Non Small Cell Lung Cancer Trial in Brussel (Checkpoint Blockade, Immune)

Recruiting
  • Breast Cancer
  • +12 more
  • Checkpoint Blockade, Immune
  • Brussel, Anderlecht, Belgium
    Institut Jules Bordet
Jul 1, 2022

Invasive Ductal Breast Carcinoma, Invasive Ductal Breast Carcinoma Stage IV, Lobular Breast Carcinoma Trial in United States

Recruiting
  • Invasive Ductal Breast Carcinoma
  • +14 more
  • Stereotactic body radiotherapy
  • Lattice Radiation Therapy
  • Basking Ridge, New Jersey
  • +6 more
Apr 20, 2023

Lung Cancer Non Small Cell, Head and Neck Squamous Cell Carcinoma, Urothelial Carcinoma Bladder Trial in Spain, United Kingdom,

Recruiting
  • Lung Cancer Non Small Cell
  • +2 more
  • IO102-IO103 in combination with pembrolizumab
  • Duarte, California
  • +18 more
Dec 15, 2022

NSCLC, Gastric Cancer, Head Neck Cancer Trial (CDX-585)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +13 more
  • (no location specified)
Mar 29, 2023

s Recurrence and Response Via a Tumor Informed Assessment

Recruiting
  • Cancer
  • +4 more
  • Personalized Cancer Monitoring (PCM)
  • San Francisco, California
  • +1 more
Dec 5, 2022

ResiduAl Cancer With Liquid Biopsy Evaluation

Recruiting
  • Bladder Carcinoma
  • +14 more
  • Guardant Reveal
  • Redwood City, California
    Redwood City
Sep 7, 2022

Genitourinary Cancer, Adrenocortical Carcinoma, Non-urothelial Bladder Trial in United States (Ipilimumab, Nivolumab)

Recruiting
  • Genitourinary Cancer
  • +7 more
  • La Jolla, California
  • +5 more
Jul 5, 2022

NSCLC, Mesothelioma, Bladder Cancer Trial in Augusta (Bosutinib, Pemetrexed)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • +7 more
  • Augusta, Georgia
    Augusta University Georgia Cancer Center
Jun 10, 2022

Oncology, Solid Tumor, Non Small Cell Lung Cancer Trial in United States (MRx0518, Pembrolizumab 25 MG/1 ML Intravenous Solution

Active, not recruiting
  • Oncology
  • +5 more
  • MRx0518
  • Pembrolizumab 25 MG/1 ML Intravenous Solution [KEYTRUDA]
  • Kansas City, Kansas
  • +4 more
Jul 5, 2022

Squamous Cell Carcinoma of Head and Neck, Colo-rectal Cancer, Non Small Cell Lung Cancer Trial in Aurora, Nashville, Houston

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +4 more
  • Aurora, Colorado
  • +2 more
Apr 18, 2022

Advanced Bladder Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston (biological,

Recruiting
  • Advanced Bladder Carcinoma
  • +34 more
  • Atezolizumab
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)

Active, not recruiting
  • MSI-H Colorectal Cancer
  • +30 more
  • Badalona, Barcelona, Spain
  • +9 more
Oct 24, 2022